Research ArticleArticle
Preclinical Evaluation of the Metabolism and Disposition of RRx-001, a Novel Investigative Anticancer Agent
Jan Scicinski, Bryan Oronsky, Michael Taylor, Gang Luo, Timothy Musick, Joseph Marini, Christopher M. Adams and William L. Fitch
Drug Metabolism and Disposition September 2012, 40 (9) 1810-1816; DOI: https://doi.org/10.1124/dmd.112.046755
Jan Scicinski
RadioRx Inc., Mountain View, California (J.S., B.O.); Covance Laboratories Inc., Madison, Wisconsin (G.L., T.M., J.M.); NonClinical Safety Assessment, Mountain View, California (M.T.); and Departments of Anesthesiology (W.L.F.) and Chemistry (C.M.A.), Stanford University, Stanford, California
Bryan Oronsky
RadioRx Inc., Mountain View, California (J.S., B.O.); Covance Laboratories Inc., Madison, Wisconsin (G.L., T.M., J.M.); NonClinical Safety Assessment, Mountain View, California (M.T.); and Departments of Anesthesiology (W.L.F.) and Chemistry (C.M.A.), Stanford University, Stanford, California
Michael Taylor
RadioRx Inc., Mountain View, California (J.S., B.O.); Covance Laboratories Inc., Madison, Wisconsin (G.L., T.M., J.M.); NonClinical Safety Assessment, Mountain View, California (M.T.); and Departments of Anesthesiology (W.L.F.) and Chemistry (C.M.A.), Stanford University, Stanford, California
Gang Luo
RadioRx Inc., Mountain View, California (J.S., B.O.); Covance Laboratories Inc., Madison, Wisconsin (G.L., T.M., J.M.); NonClinical Safety Assessment, Mountain View, California (M.T.); and Departments of Anesthesiology (W.L.F.) and Chemistry (C.M.A.), Stanford University, Stanford, California
Timothy Musick
RadioRx Inc., Mountain View, California (J.S., B.O.); Covance Laboratories Inc., Madison, Wisconsin (G.L., T.M., J.M.); NonClinical Safety Assessment, Mountain View, California (M.T.); and Departments of Anesthesiology (W.L.F.) and Chemistry (C.M.A.), Stanford University, Stanford, California
Joseph Marini
RadioRx Inc., Mountain View, California (J.S., B.O.); Covance Laboratories Inc., Madison, Wisconsin (G.L., T.M., J.M.); NonClinical Safety Assessment, Mountain View, California (M.T.); and Departments of Anesthesiology (W.L.F.) and Chemistry (C.M.A.), Stanford University, Stanford, California
Christopher M. Adams
RadioRx Inc., Mountain View, California (J.S., B.O.); Covance Laboratories Inc., Madison, Wisconsin (G.L., T.M., J.M.); NonClinical Safety Assessment, Mountain View, California (M.T.); and Departments of Anesthesiology (W.L.F.) and Chemistry (C.M.A.), Stanford University, Stanford, California
William L. Fitch
RadioRx Inc., Mountain View, California (J.S., B.O.); Covance Laboratories Inc., Madison, Wisconsin (G.L., T.M., J.M.); NonClinical Safety Assessment, Mountain View, California (M.T.); and Departments of Anesthesiology (W.L.F.) and Chemistry (C.M.A.), Stanford University, Stanford, California
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
METABOLISM AND DISPOSITION OF RRx-001
Jan Scicinski, Bryan Oronsky, Michael Taylor, Gang Luo, Timothy Musick, Joseph Marini, Christopher M. Adams and William L. Fitch
Drug Metabolism and Disposition September 1, 2012, 40 (9) 1810-1816; DOI: https://doi.org/10.1124/dmd.112.046755
Research ArticleArticle
METABOLISM AND DISPOSITION OF RRx-001
Jan Scicinski, Bryan Oronsky, Michael Taylor, Gang Luo, Timothy Musick, Joseph Marini, Christopher M. Adams and William L. Fitch
Drug Metabolism and Disposition September 1, 2012, 40 (9) 1810-1816; DOI: https://doi.org/10.1124/dmd.112.046755
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement